{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:57Z","timestamp":1789070757427,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL158521"],"award-info":[{"award-number":["R01HL158521"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F31HL176172"],"award-info":[{"award-number":["F31HL176172"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jneuroim.2025.578705","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:06:35Z","timestamp":1753369595000},"page":"578705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Beta adrenergic signaling as a therapeutic target for autoimmunity"],"prefix":"10.1016","volume":"407","author":[{"given":"Tatlock H.","family":"Lauten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Natour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline N.","family":"Jojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578705_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","article-title":"5-HT and the immune system","volume":"11","author":"Ahern","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0015","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.celrep.2019.08.042","article-title":"The sympathetic nervous system mitigates CNS autoimmunity via \u03b22-adrenergic receptor Signaling in immune cells","volume":"28","author":"Araujo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000129670","article-title":"Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function","volume":"14","author":"Bao","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588724","article-title":"Can Beta-2-adrenergic pathway be a new target to combat SARS-CoV-2 hyperinflammatory syndrome?-lessons learned from cancer","volume":"11","author":"Barbieri","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1189\/jlb.0209107","article-title":"The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism","volume":"86","author":"Bhowmick","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13311-015-0405-3","article-title":"Neuroimmunotherapies targeting T cells: from pathophysiology to therapeutic applications","volume":"13","author":"Bittner","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0040","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.33431","article-title":"First appearance and location of catecholaminergic cells during experimental arthritis and elimination by chemical sympathectomy","volume":"64","author":"Capellino","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164609","article-title":"Mitochondrial superoxide Signaling contributes to norepinephrine-mediated T-lymphocyte cytokine profiles","volume":"11","author":"Case","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-5728(88)90125-7","article-title":"Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis","volume":"17","author":"Chelmicka-Schorr","year":"1988","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-5728(89)90138-0","article-title":"The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats","volume":"25","author":"Chelmicka-Schorr","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-5728(92)90160-M","article-title":"Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis","volume":"37","author":"Chelmicka-Schorr","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0070","first-page":"544","article-title":"Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action","volume":"85","author":"Cook-Mills","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104293","article-title":"Autonomic regulation of T-lymphocytes: implications in cardiovascular disease","volume":"146","author":"Elkhatib","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2022.05.007","article-title":"T-lymphocyte tyrosine hydroxylase regulates T H 17 T-lymphocytes during repeated social defeat stress","volume":"104","author":"Elkhatib","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0361-9230(84)90230-2","article-title":"Sympathetic innervation of lymph nodes in mice","volume":"13","author":"Felten","year":"1984","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0090","doi-asserted-by":"crossref","first-page":"755s","DOI":"10.4049\/jimmunol.135.2.755","article-title":"Noradrenergic and peptidergic innervation of lymphoid tissue","volume":"135","author":"Felten","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0095","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.410080509","article-title":"Lymph nodes--a possible site for sympathetic neuronal regulation of immune responses","volume":"8","author":"Giron","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b2 1 -adrenergic receptor links sympathetic nerves to T cell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pupt.2007.07.002","article-title":"The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study","volume":"21","author":"Hanania","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00415-011-5996-y","article-title":"De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate","volume":"258","author":"Havla","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029637","article-title":"The interleukin (IL)-23\/T helper (Th)17 Axis in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"8","author":"Hiltensperger","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000360579","article-title":"Regulation of differentiation and function of helper T cells by lymphocyte-derived catecholamines via alpha(1)- and beta(2)-adrenoceptors","volume":"22","author":"Huang","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110039","article-title":"SARS-CoV-2 and the sympathetic immune response: dampening inflammation with antihypertensive drugs (clonidine and propranolol)","volume":"144","author":"Hyoju","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1189\/jlb.1105625","article-title":"It takes nerve to tell T and B cells what to do","volume":"79","author":"Kin","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-006-0296-7","article-title":"Tremor in multiple sclerosis","volume":"254","author":"Koch","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0150","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/1389450117666160307144027","article-title":"IL-17A and multiple sclerosis: Signaling pathways, producing cells and target cells in the central nervous system","volume":"17","author":"Kolbinger","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5966\/sctm.2015-0065","article-title":"Propranolol and mesenchymal stromal cells combine to treat traumatic brain injury","volume":"5","author":"Kota","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbi.2024.11.013","article-title":"T H 17\/Treg lymphocyte balance is regulated by beta adrenergic and cAMP signaling","volume":"123","author":"Lauten","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0889-1591(91)90028-9","article-title":"Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis","volume":"5","author":"Leonard","year":"1991","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0185","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-019-09852-3","article-title":"Dopaminergic therapeutics in multiple sclerosis: focus on Th17-cell functions","volume":"15","author":"Melnikov","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020668","article-title":"The dual role of the \u03b2 2 -adrenoreceptor in the modulation of IL-17 and IFN-\u03b3 production by T cells in multiple sclerosis","volume":"23","author":"Melnikov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bpsgos.2022.12.002","article-title":"S100a9 protects against the effects of repeated social defeat stress","volume":"3","author":"Moshfegh","year":"2023","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbi.2007.03.008","article-title":"Autonomic innervation and regulation of the immune system (1987-2007)","volume":"21","author":"Nance","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2018.09.001","article-title":"IL-17 and limits of success","volume":"339","author":"Omidian","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/187152410790780154","article-title":"Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands","volume":"10","author":"Pacheco","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.smim.2014.01.003","article-title":"Neuroendocrine regulation of inflammation","volume":"26","author":"Padro","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000065183","article-title":"Autonomic regulation of experimental autoimmune encephalomyelitis: the role of interferon-gamma","volume":"10","author":"P\u00e1l","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-5728(99)00209-X","article-title":"Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice","volume":"100","author":"P\u00e1l","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104665","article-title":"Propranolol diminished severity of rat EAE by enhancing immunoregulatory\/protective properties of spinal cord microglia","volume":"134","author":"Pilipovi\u0107","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0245","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10571-022-01246-z","article-title":"\u0392-Adrenoceptor blockade moderates neuroinflammation in male and female EAE rats and abrogates sexual dimorphisms in the major neuroinflammatory pathways by being more efficient in males","volume":"43","author":"Pilipovi\u0107","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","article-title":"The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?","volume":"26","author":"Sanders","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/brbi.2001.0639","article-title":"Norepinephrine, the beta-adrenergic receptor, and immunity","volume":"16","author":"Sanders","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0260","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1749-6632.2000.tb05427.x","article-title":"In vivo immunomodulation by peripheral adrenergic and cholinergic agonists\/antagonists in rat and mouse models","volume":"917","author":"Schauenstein","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0265","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1084\/jem.20140540","article-title":"VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells","volume":"211","author":"Schneider-Hohendorf","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ebiom.2017.10.010","article-title":"Cyclic AMP-responsive element-binding protein (CREB) is critical in autoimmunity by promoting Th17 but inhibiting Treg cell differentiation","volume":"25","author":"Wang","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jneuroim.2025.578705_bb0275","first-page":"320","article-title":"IL-17 neutralization by subcutaneous CJM112, a fully human anti IL-17A monoclonal antibody for the treatment of relapsing-remitting multiple sclerosis: study design of a phase 2 trial","volume":"21","author":"Wiendl","year":"2015","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2025.578705_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0038-1649502","article-title":"Multiple Sclerosis","volume":"38","author":"Yamout","year":"2018","journal-title":"Semin. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:51:08Z","timestamp":1779616268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":56,"alternative-id":["S0165572825001869"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578705","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.05.647384","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta adrenergic signaling as a therapeutic target for autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578705"}}